Allcure Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 08-12-2024
- Paid Up Capital ₹ 0.10 M
as on 08-12-2024
- Company Age 3 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
About Allcure Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Priyadarshi Sharma, Aaditya Sharma, Sachin Goel, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24230HR2021PTC094788
- Company No.
094788
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Apr 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Yamuna Nagar, Haryana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Allcure Lifesciences?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Priyadarshi Sharma  | Director | 29-Apr-2021 | Current |
| Aaditya Sharma | Director | 29-Apr-2021 | Current |
| Sachin Goel | Director | 29-Apr-2021 | Current |
| Mahesh Kumar | Director | 29-Apr-2021 | Current |
| Mayank Goel | Director | 29-Apr-2021 | Current |
Financial Performance and Corporate Structure Insights of Allcure Lifesciences.
Allcure Lifesciences Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Allcure Lifesciences?
In 2023, Allcure Lifesciences had a public holding of 60.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Bhrigu Pharma Private LimitedActive 11 years 5 monthsPriyadarshi Sharma and Aaditya Sharma are mutual person
- Shining Ayurveda Private LimitedActive 8 years 6 months
Priyadarshi Sharma and Aaditya Sharma are mutual person
- Allcure Remedies LlpActive 7 years 5 months
Aaditya Sharma, Sachin Goel and 2 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Allcure Lifesciences?
Allcure Lifesciences has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Allcure Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Allcure Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
